-
公开(公告)号:EP2758532B1
公开(公告)日:2018-07-11
申请号:EP12766050.4
申请日:2012-09-20
发明人: FRENDÉUS, Björn , MATTSSON, Jenny
CPC分类号: G01N33/566 , C12N15/1037 , G01N33/6845 , G01N33/6857 , G01N2500/00
摘要: The present invention relates to improved screening methods and, in particular, to methods of screening anti-ligand libraries for identifying anti-ligands specific for differentially and/or infrequently expressed ligands.
-
公开(公告)号:EP3142696A1
公开(公告)日:2017-03-22
申请号:EP15723491.5
申请日:2015-05-15
IPC分类号: A61K39/395 , C07K16/28 , C07K16/30 , A61P35/00 , A01K67/027
CPC分类号: C07K16/2887 , A61K2039/507 , A61K2039/55 , C07K16/283 , C07K16/2893 , C07K16/30 , C07K2317/21 , C07K2317/33 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/732 , C07K2317/75 , C07K2317/76 , C07K2317/77 , C07K2317/92 , C07K2317/94
摘要: Description of a composition comprising an antibody molecule and an agent for use in the treatment of refractory cancer and/or relapsed cancer, and of a method of treating refractory cancer and/or relapsed cancer comprising administering an antibody molecule and an agent. There are also described kits comprising the antibody molecule and agents.
摘要翻译: 包含抗体分子和用于治疗顽固性癌症和/或复发性癌症的试剂的组合物的描述,以及治疗难治性癌症和/或复发性癌症的方法,包括施用抗体分子和试剂。 还描述了包含抗体分子和试剂的试剂盒。
-
公开(公告)号:EP0988378B9
公开(公告)日:2010-08-04
申请号:EP98901380.0
申请日:1998-01-26
CPC分类号: C12N15/102 , C07K16/00 , C07K16/44 , C07K2317/622 , C07K2317/92 , C12N15/1027 , C12N15/1031 , C12N15/1058 , C12N15/1086 , Y10T436/143333
-
公开(公告)号:EP1604209B1
公开(公告)日:2008-10-22
申请号:EP04719437.8
申请日:2004-03-11
发明人: NILSSON, Fredrik
CPC分类号: G01N33/6848 , G01N33/6842 , G01N33/6851
摘要: The present invention relates to a method for analysing a heterogeneous sample of proteins, peptides or fragments thereof, the method comprising (a) separating the heterogeneous sample of proteins, peptides or fragments thereof into heterogeneous classes by binding members of each class to a spaced apart defined location on an array, wherein members of each class have a motif common to that class; and (b) characterising the proteins, peptides or fragments thereof in each class.
-
公开(公告)号:EP1879919A2
公开(公告)日:2008-01-23
申请号:EP06753524.5
申请日:2006-04-28
发明人: HOLMGREN, Lars
摘要: The present invention relates to prophylactic or therapeutic treatments for hindering blood vessel formation (for example, angiogenesis) for example for hindering tumour growth. In particular, the invention relates to a vaccine or medicament comprising a whole angiomotin molecule or a fragment thereof which may be used to generate immune responses to angiomotin. The invention also provides antibodies specific for a whole angiomotin molecule or a fragment thereof for use in prophylactic or therapeutic treatments.
摘要翻译: 本发明涉及阻止血管形成(例如血管发生)的预防或治疗方法,例如阻止肿瘤生长。 特别地,本发明涉及包含可用于产生对血管动蛋白的免疫应答的完整血管动蛋白分子或其片段的疫苗或药物。 本发明还提供了用于预防或治疗性治疗的整个血管动蛋白分子或其片段特异的抗体。
-
公开(公告)号:EP1268801B1
公开(公告)日:2004-06-23
申请号:EP01925538.9
申请日:2001-04-04
发明人: OHLIN, Mats , SODERLIND, Eskil , CARLSSON, Roland
CPC分类号: C12N15/1058 , C07K16/00 , C07K2317/56 , C07K2317/565 , C07K2317/567 , C07K2317/622 , C40B10/00
摘要: The present invention provides a method for producing a polynucleotide sequence encoding an antibody variable domain, the variable domain comprising complementarity-determining regions (CDRs) located within a selected framework (the 'master framework'), the method comprising the steps of (a) providing at least one nucleic acid molecule encoding one or more CDRs and associated framework regions (the 'original framework'), (b) amplifying at least one CDR-encoding portion of the nucleic acid molecule(s) of step (a) using one or more pairs of oligonucleotides as amplification primers and (c) assembling a polynucleotide sequence encoding an antibody variable domain by combining the amplified CDR-encoding nucleotide sequences produced in step (b) with nucleotide sequences encoding said master framework, wherein the oligonucleotide primers of step (b) comprise nucleotide sequences which differ from the corresponding nucleotide sequences encoding said master framework. The invention further provides an antibody library, such as a phage display library, and methods of making the same.
-
公开(公告)号:EP0990044A1
公开(公告)日:2000-04-05
申请号:EP98930871.3
申请日:1998-06-16
发明人: BORREBAECK, Carl, Arne, Krister , SÖDERLIND, Ulf, Hans, Eskil , OTTOSSON, Rebecka, Ingrid, Camilla
IPC分类号: C12Q1/68
CPC分类号: C40B40/02 , C12N15/1027 , C12N15/1037 , C12Q1/6811 , C12Q1/6858 , C12Q2521/319
摘要: The present invention relates to a method for in vitro evolution of protein function. In particular, the method relates to the shuffling of nucleotide segments obtained from exonuclease digestion. The present inventors have shown that polynucleotide fragments derived from a parent polynucleotide sequence digested with an exonuclease can be combined to generate a polynucleotide sequence which encodes for a polypeptide having desired characteristics. This method may be usefully applied to the generation of new antibodies or parts thereof having modified characteristics as compared to the parent antibody.
-
公开(公告)号:EP4405050A1
公开(公告)日:2024-07-31
申请号:EP22782722.7
申请日:2022-09-21
-
公开(公告)号:EP3414267B1
公开(公告)日:2023-12-27
申请号:EP17704727.1
申请日:2017-02-09
发明人: ABRAHAM, Reimar , FUKUCHI, Keisuke
IPC分类号: C07K16/28 , A61K39/395 , A61K31/4412 , A61P35/00 , A61K39/00 , A61K31/44 , A61K38/20
-
10.
公开(公告)号:EP3658587A2
公开(公告)日:2020-06-03
申请号:EP18753084.5
申请日:2018-07-26
-
-
-
-
-
-
-
-
-